H3N2 Influenza Nosode

FDA Drug Profile — H3N2 Influenza Nosode 4449

Drug Details

Generic Name
H3N2 Influenza Nosode
Brand Names
H3N2 Influenza Nosode 4449
Application Number
Sponsor
Professional Complementary Health Formulas
NDC Codes
1
Dosage Forms
LIQUID
Routes
ORAL
Active Ingredients
INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) NEURAMINIDASE ANTIGEN (PROPIOLACTONE INACTIVATED)

Indications and Usage

INDICATIONS For the temporary relief of chills, cough, minor sore throat, occasional headache, muscle aches, or fatigue.*

Warnings

WARNINGS Persistent symptoms may be a sign of a serious condition. If symptoms persist or are accompanied by a fever, rash, or persistent headache, consult a doctor. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.